Toxicology Laboratory Updates

Slides:



Advertisements
Similar presentations
LABORATORY CERTIFICATION & DATA QUALITY MICHAEL W. MILLER, Ph.D. NJ-DEP Office of Quality Assurance
Advertisements

Figure 1. Denali KidCare Enrollment for Alaska Native Children January 2006–July 2007 Citizenship documentation rules implemented Source: Alaska Department.
Prescription Drug Abuse And The Toxicology Of Medication Monitoring
An Essential Component of Crime Scene Investigation.
JAN is a service of the U.S. Department of Labor’s Office of Disability Employment Policy. 1 Drugs and Alcohol Under the ADA Linda Carter Batiste, J.D.,
OVERDOSE SOLUTIONS 2013 OVERDOSE DATA FOR ALLEGHENY COUNTY Jennifer Janssen Manager Toxicology Laboratory Allegheny County Office of the Medical Examiner.
Alcohol Misuse and Crime: Update on Federal Reporting Fourth meeting of National Partnership on Alcohol Misuse and Crime National Partnership on Alcohol.
Affordable Care Act Impacts Requires employers and employees to share responsibility in making sure individuals have health insurance. Requires employers.
FT MEADE DoD CIVILIAN PROGRAM UPDATE
879 Productions Presents Copyright 2000 Alcohol, Drugs & Driving with Officer Darin “Crash” Leonard.
HR: Leading People, Leading Organizations © 2007 SHRM SHRM Weekly Online Survey: January 9, 2007 Family Medical Leave Sample comprised of 344 randomly.
Connecticut Rider Education Program Annual Update.
Royal Montserrat Police Service Monthly Crime Report – May 2012 Monthly Crime Report Restricted.
Drug Impaired Driving: Importance of Toxicology in Assessing the Problem and Developing Countermeasures McGovern Award Dinner Cosmos Club, Washington DC,
ANGELINA CAPORICCIO. MAIN POINTS  STATISTICS  WHY DRINKING AND DRIVING IS DANGEROUS  WHAT IS EFFECTS  CONSEQUENCE’S OF DRINKING AND DRIVING  SIGNS.
Temporary Employment What’s Changing?. BOR Policy Change – Employment Categories 2 BOR Employment Categories policy modified (August 2010). Helps to ensure.
Karl Williams, MD, MPH Medical Examiner Allegheny County.
Experiences of a Newly Accredited Laboratory
Forensic Toxicology Father of Modern Toxicology.
INSIDE THE IDAHO STATE POLICE FORENSIC SERVICES LABORATORIES Judges Webinar January 8, 2014 Matthew Gamette Laboratory Improvement Manager.
AUTHORIZATION STEPS Fingerprinting Authorizations Responsibilities School Bus Driver Inservice
CONTROLLED SUBSTANCES AND ALCOHOL USE TESTING REGULATIONS FOR MANAGEMENT.
1 Vicki Cutcliffe Chief 2012 Bureau of Law Enforcement.
Barry K Logan PhD, D-ABFT Impact of Changing Marijuana Laws on Impaired Driving.
Alcohol & drugs Driver. Name of person who will answer driver questions about the materials Drivers subject to Part 382 1a Information drivers must receive.
OFFICE OF MEDICAL CANNABIS Task Force on Medical Cannabis Therapeutic Research Meeting Wednesday September 10, :30pm Manny Munson-Regala and Michelle.
Obstacles, Challenges & Resistance Niagara Frontier Transportation Authority Concerns  Understaffing resulting in “work’ being cut.  Employee compensation.
Department of Health and Social Services Office of the Chief Medical Examiner Joint Finance Committee Hearing Fiscal Year 2014 Richard T. Callery, M.D.,
The Kansas Communities That Care Survey Process and Administration.
Workforce Productivity Team Phase 1 Update 9/14/2015 Draft for Discussion & Policy Purposes Only1.
Chapter 6 Driving Privileges and Penalties. How to Lose Driving Privileges failure to appear in court or to pay fines failure to pay surcharges driving.
FORENSIC DNA ASSESSMENT Presented by: Smith Alling Lane, P.S. Tacoma, WA (253) Washington, DC (202) London 011 (44) Tim.
Why You Should Not Drink and Drive David Mockus Penn State Hazleton CAS 100A- 07.
And other Lies and Damned Lies
Law 120.  The law must seek a balance between an individual’s right to privacy and the state’s need to conduct a thorough investigation.  Statute and.
Toxicology Laboratory Updates DRE In-Service, March 2010 Dr. Fiona Couper, State Toxicologist Brian Capron, Supervisor/Forensic Toxicologist.
A pilgrimage of a lifetime introducing WYD KRAKOV March 2014.
Drugged Driving Margaret Hague. New Epidemic Drinking and driving has been a major concern for a long time. Not only is texting and driving becoming a.
Pedestrian Crash Briefing Aug 2008 NHTSA’s National Center for Statistics & Analysis 1 Author: Dow Chang NHTSA Technical.
Time Report Training Revised April 2015 Presented by: Human Resource Services.
May 2016 Prevalence of Marijuana Involvement in Fatal Crashes: Washington
A new approach to continuing competence Julie Brannan - Director of Education and Training Maxine Warr - Policy Manager Richard Williams - Policy Associate.
Hourly Student Employees Getting Them Hired & Records Management Best Practices.
TBI Toxicology Overview Steps taken and progress achieved in reducing the turnaround time for the TBI Toxicology Unit Steps taken and progress achieved.
How many of Colorado’s DUIs are DUIDs? CTFDID November, 2014.
May 2016 Cannabis Use among Drivers Suspected of Driving Under the Influence or Involved in Collisions: Analysis of Washington State Patrol Data.
Marijuana Involvement in Fatal Crashes Staci Hoff, PhD Research Director (360)
Department of Human Resources
The DRE Program and Drug Impaired Driving
Impact of legalized recreational marijuana in Washington State
Poly-substance Impaired Drivers
Payroll User Group Meeting
OTETA Omnibus Transportation Employee Testing Act Regulatory Update
Forensic Toxicology Kseniya Konovalenko.
APICS CPIM Reconfiguration Timeline
CANNABIS AND CANNABINOIDS: THE CONUNDRUM
12 Passenger Van Safety Training
Becky Bui Colorado Department of Public Safety
Forensic toxicology.
NC Truck Driver Training SCHOOL
Youth Driving Under the Influence of Marijuana
AAA Drugged Driving Summit│ January 26, 2015 │ Tampa, FL
Drug trends: The Vermont perspective
Role of Toxicology in Criminal Investigations
Broward Quality Performance Review
EU Projects in 2006 January 11th, 2006.
Drugs of Abuse Service: Urine and oral fluid testing Dr Paul Cawood Toxicology, Clinical Biochemistry, RIE GP-Laboratory Medicine Update Meeting 11th.
Drug and Alcohol Supervisor Training
PBIS Update January 2006.
Marijuana Involvement in Fatal Crashes
Presentation transcript:

Toxicology Laboratory Updates Washington State Toxicology Lab Washington State Patrol Brian Capron

Laboratory Staffing Updates New Laboratory Manger: Dr. Brianna Peterson Two toxicologists still on maternity leave Lisa Noble (return November) Rebecca Flaherty (return December) Four new toxicologists hired: Amanda Chandler- finishing training Lyndsey Lowe- doing case work Katie Knorr- doing case work Andrew Gingras- in training

Laboratory Staffing Updates Currently have 7 toxicologists performing work on driving cases and testifying in trials (WA and AK) Supervisor position filled by Lisa Noble who returns next month Administrative position still open Lab will not be fully staffed until late December when last person returns from maternity leave Two new hires are doing case work (death cases) while the other two are finishing their training Dawn Sklerov has returned and will be starting case work in a few weeks

Validated Methods We have introduced over 10 new validated methods in the past few years with more in the future Validated methods undergo rigorous scientific testing to ensure that we are providing the best possible results to our customers Validation is an important necessity for laboratory accreditation Validated methods produce high-quality results that are easier to defend in court Validated methods take months to be developed and tested (time consuming)

Toxicologist Certifications Newly introduced methods require toxicologists to become certified to perform them Usually a three to four stage process First stages require testing calibrators and controls Last stages require testing spiked samples Results undergo peer review by QA department Toxicologists receive an authorization letter to perform the testing Trying to get all toxicologist to perform their own work on all driving cases (court rulings)

New Testing Policy in 2013 Effective January 1, 2013: All driving cases will be tested for alcohol and drugs regardless of alcohol level (change from the past) All vehicular assault/homicide cases will undergo full toxicology testing Causing/unknown drivers in fatalities will undergo full toxicology testing Pedestrians will undergo alcohol and drug testing All testing results will appear on reports if the test has been performed (even negative results)

New Testing Policy in 2013 Changes require the toxicologist to perform more testing on every sample (turn around times) As a result, we are seeing many more drivers with alcohol levels >.10 that also have drugs present If you suspect alcohol only, please request “blood alcohol only” in writing on the request form otherwise we are required by our policy to perform drug testing as well

Toxicology Lab-YTD (Jan-Dec ‘12) Year % change YTD 2012 YTD 2011 YTD 2010 YTD # total cases - 10,995 10,962 10,547 postmortem 4,975 4,964 4,592 DUI/DRE ↑ 3% 5,838 5,682 5,524 other case types ↓ 43% 182 319 431 TAT-testing ↓ 3 days 13 days 16 days 21 days DUI/DRE cases ↓ 9/20 days 14/22 days 15/29 days TAT-lab report 15 days 19 days # analysts 11 12 # court cases ↑ 6% 419 396 345 # court hours ↓ 6% 2,151 hr 2,292 hr 2,030 hr # discovery requests ↓ 35% 272 417 437

Toxicology Lab- 2012 DUI/DRE summary 2012 stats (N=5,838) 2011 stats (N=5,682) THC (metabolite) 18% (29%) 20% (29%) Methamphetamine 10.5% 9.6% Alprazolam 6.1% 6.4% Oxycodone 3.9% 4.2% Diazepam 3.6% 4.5% Zolpidem 3.3% 3.2% Methadone Clonazepam 3.0% 3.5%

Toxicology Lab-YTD (Jan-Aug ‘13) Year % change YTD 2013 YTD 2012 YTD 2011 YTD # total cases ↑ 3.4% 7,599 7,349 7,418 postmortem ↑ 2.2% 3,413 3,342 3,350 DUI cases ↑6.8% 3,373 3,159 2,932 DRE cases ↓16% 606 723 901 Other case types ↑ 65% 206 125 235 TAT (median) 5 days 19 days 14 days 15 days # analysts ↓ 6 FTE 6 12 # court cases - 294 297 252 # court hours ↓5% 1,529 hrs 1,608 hrs 1,459 hrs

Toxicology Lab-THC Statistics (YTD) Data Jan-July 2013 Jan-July 2012 Jan-July 2011 THC DUI/DRE cases 850 (27%) 575 (19%) 618 (17%) Percent male 81% 77% 85% Age 14-74 yr (avg 29) 16-66 yr (avg 28) 16-65 yr (avg 28) % of cases < 21 yr 27% 24% 33% THC concentration 2-77 ng/mL 1-58 ng/mL 1-59 ng/mL (avg 8.2 med 5.7) (avg 7.6 med 5.8) (avg 6.2 med 4.5) Combined with other drugs Alcohol 276 (32%) 151 (26%) 104 (17%) Methamphetamine 65 (8%) 33 (6%) 42 (7%) Alprazolam 36 (<5%) 30 (5%) 26 (<5%) Oxycodone 34 (<5%) 24 (<5%)

Toxicology Lab: I-502 Impact Projected 2013: based on data from Jan 1, 2013 though June 30, 2013

Toxicology Lab: I-502 Impact YTD 2013: Jan 1, 2013 through June 30, 2013

Toxicology Lab- LCB Evidence

Toxicology Lab- THC case History ∙ 45 year old male ∙ SPD case- stopped for vehicle license violation ∙ Strong odor of marijuana in car and on subject ∙ Driver showed impairment on FST’s, had watery/red eyes ∙ Admitted past Marinol use and that passenger had been smoking marijuana Testing ∙ THC 84 ng/mL ∙ carboxy-THC 720 ng/mL Comments ∙ Passive inhalation: THC <1-2 ng/mL (~20 mins) with a corresponding low carboxy-THC

Drugs we send out for testing Synthetic cannabinoids Buprenorphine (Suboxone) Lithium Risperidal Bath salts* Psilocybin Gabapentin LSD Methocarbamol Mitragynine (Kratom)*

EMIT testing limitations Testing used to see if any drug classes are positive/negative Categories include: Cocaine metabolite Opiates Benzodiazepines Barbiturates Cannabinoids Amphetamines Phencyclidine Propoxyphene* (no longer testing for) Methadone Tricyclic anti-depressants

EMIT testing limitations Class specific, not compound specific Not completely comprehensive (Ambien, Benadryl) Each drug has a “cut-off” level Drugs may be present below the “cut-off” “Cut-off” established through validation testing Designed to reveal clinically significant levels Some compounds cross-react (THC, Amphetamines) Some drugs are poor reactors and may not produce a positive result unless the level is significantly high

EMIT testing limitations Benzodiazepines (specific to Diazepam): Alprazolam, Clonazpeam and Lorazepam react poorly so we do confirmations on elevated responses Amphetamines (specific to Amp/Meth): Amines often do not screen “positive”, but we move to confirmation testing when an elevation is seen Phencyclidine: large amounts of Dextromethorphan can causes positive response (use GC/MS) Opiates (specific to Morphine): may not confirm positive if only morphine glucuronides are present

Quantitation limits Amines: 0.05 mg/L Barbiturates: 0.5 mg/L Benzodiazepines: 0.01 mg/L Cannabinoids: THC 2 ng/mL*, carboxy-THC 10 ng/mL* Cocaine: 0.01 mg/L Carisprodol/Meprobamate: 1.0 mg/L Fentanyl: 2.5 ng/mL Methadone: 0.01 mg/L Opiates: 0.01 mg/L* (HYM/6-AM: 2 ng/mL) added Oxymorphone* to the method PCP: 0.01 mg/L Zolpidem: 0.01 mg/L

Case #1 Stopped for erratic driving Strong smell of alcohol Resisted arrest and faked seizures Submitted as an alcohol only case Toxicology results: Ethanol = .25 g/100mL Hydrocodone = 0.16 mg/L Topiramate = 5.6 mg/L

Case #2 Stopped for driving on the shoulder Strong odor of intoxicants Submitted as an alcohol only Felony DUI Toxicology results: Ethanol = .12 g/100mL THC = 8 ng/mL Carboxy-THC = >200 ng/mL

Case #3 Stopped for speeding Refused SFST’s Obvious signs of impairment Request form states 8 prior DUI’s Submitted as an alcohol only Toxicology results: Ethanol = 0.19 g/100mL THC = 6.1 ng/mL Carboxy-THC = 100 ng/mL

Looking Forward Continue to develop new methods to detect emerging drugs seen in the driving population Electronic submissions forms and electronic reports is a future goal ASCLD/LAB accreditation Fully staffed lab within the next year New laboratory instrumentation (LC/MS/MS) Continue to increase communication between the laboratory and the DRE program

Helpful reminders Please include the DRE face sheet when submitting the sample for testing This is important because we do specific testing based upon your observations Please list the drugs suspected so the appropriate testing can be performed Remember some drugs do not react well on the initial screening Please call the laboratory if you have any questions or concerns

Questions Contact information: 206-262-6100 brian.capron@wsp.wa.gov